China NMPA Drug Inspection - Jilin Province Cross-Sea Biochemical Pharmaceutical Manufacturing Co., Ltd. - Ginkgo leaf medicine
China NMPA drug inspection for Jilin Province Cross-Sea Biochemical Pharmaceutical Manufacturing Co., Ltd. published July 31, 2015. Drug: Ginkgo leaf medicine. The State Food and Drug Administration (SFDA) of China conducted special supervision and sampling inspections of Ginkgo
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Jilin Province Cross-Sea Biochemical Pharmaceutical Manufacturing Co., Ltd. published July 31, 2015. Drug: Ginkgo leaf medicine. The State Food and Drug Administration (SFDA) of China conducted special supervision and sampling inspections of Ginkgo
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox